977705

STI Pharma LLC — FEI 3008910005

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 21, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Newtown, PA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673021 CFR 314.80(b)Failure to develop written procedures